Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-10-04FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation…
-
FDA approval · 2012-10-04FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EDARBI (azilsartan medoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2012-10-04FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR, the fixed-dose combination of azilsartan medoxomil and chlorthalidone, developed…
-
FDA approval · 2012-10-03FDA Approved: IRBESARTAN — Original Application (NorthStar RxLLC)
FDA approves the original ANDA for irbesartan (IRBESARTAN) from NorthStar RxLLC as a generic version of the hypertension medicine.
-
FDA approval · 2012-09-28FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination antihypertensive (amlodipine/valsartan/hydrochlorothiazide…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-09-28FDA Approved: COZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2012-09-28FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for aliskiren hemifumarate submitted by Prasco Laboratories.
-
FDA approval · 2012-09-28FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Exforge (amlodipine besylate and valsartan) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2012-09-28FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, In…
-
FDA approval · 2012-09-28FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besilate / hydrochlorothiazide) from Cosette Ph…
-
FDA approval · 2012-09-28FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.
-
FDA approval · 2012-09-28FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar (olmesartan medoxomil) by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2012-09-27FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Dr. Reddy's to market amlodipine besylate and benazepril hydrochloride as a combination antihype…
-
FDA approval · 2012-09-27FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's supplemental application for a generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride.
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Solco Healthcare U.S., LLC)
FDA approved the original application for IRBESARTAN from Solco Healthcare U.S., LLC, granting approval to market a generic version of irbes…
-
FDA approval · 2012-09-27FDA Tentative Approval: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA has issued tentative approval for Macleods Pharmaceuticals' generic fixed-dose combination of irbesartan and hydrochlorothiazide for hyp…
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic irbesartan product from Camber Pharmaceuticals through an original ANDA. The product is indicated for hypertension an…
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Original Application for IRBESARTAN, authorizing the marketing of the generic irbesartan. The approv…
-
FDA approval · 2012-09-26FDA Approved: TORSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for torsemide from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2012-09-24FDA Approved: LOSARTAN POTASSIUM — Original Application (Micro Labs Limited)
FDA approved Losartan potassium under an Original Application for Micro Labs Limited.
-
FDA approval · 2012-09-24FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for generic hydrochlorothiazide. The drug is indicated for hypertension and edema.
-
FDA approval · 2012-09-21FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2012-09-21FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA supplemental approval for Benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC) to update labeling related to the product.
-
FDA approval · 2012-09-21FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the Original Application for a generic fixed-dose combination of valsartan and hydrochlorothiazide, manufactured by Mylan. The …
-
FDA approval · 2012-09-20FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Micardis (telmisartan) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.